EPIRUS is focusing on the central development of a broad pipeline of biosimilar monoclonal antibodies and therapeutic proteins, optimized for use within the SCALE™ disposable manufacturing system, and designed to be deployed in an "In Market, For Market" ™ manufacturing configuration.
Current Team (10)Update
Vice President of Program Management
Senior Director of Bioprocess Development
President and CEO
Vice President of Manufacturing and Quality
Senior Vice President of Business Development
Director of Finance and Strategy
Chief Business Officer
Chief Financial Officer
Funding Rounds (3) - $36MUpdate
Board Members and Advisors (6)Update
Gibralt Capital Corporation is a Vancouver, Canada based alternative asset manager. Gibralt...
Adage Capital Management is a Boston-based $8.9B Money Management firm focused on managing...
Mousse Partners, Ltd. is a family office specializing in venture capital investments. It seeks to...
Montreux Equity Partners is a private investment firm dedicated to building the leading...
Venture capital Firm
699 Boylston Street
Boston, MA 02116